OncoTargets and Therapy
Volume 9, 2016 - Issue
Open access
59
Views
6
CrossRef citations to date
0
Altmetric
Original Research
Dendritic cell immunotherapy versus bevacizumab plus irinotecan in recurrent malignant glioma patients: a survival gain analysis
Stefan-Alexandru Artene1 Unit of Biochemistry
, Adina Turcu-Stiolica2 Department of Biostatistics
, Richard Hartley1 Unit of Biochemistry
, Marius Eugen Ciurea3 Department of Plastic and Reconstructive Surgery
, Oana Daianu1 Unit of Biochemistry
, Corina Brindusa1 Unit of Biochemistry
, Oana Alexandru4 Department of Neurology, University of Medicine and Pharmacy of Craiova, Craiova
, Ligia Gabriela Tataranu5 Department of Neurosurgery, “Bagdasar–Arseni” Emergency Hospital, Bucharest, Romania
, Stefana Oana Purcaru1 Unit of Biochemistry
& Anica Dricu1 Unit of BiochemistryCorrespondence[email protected]
show all
Pages 6669-6677
|
Published online: 04 Nov 2016
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.